Pharmaceutical Processing

The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News

Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Emerson and GE Collaborate on Protein Purification Systems

November 8, 2004 11:32 am | Product Releases | Comments

AUSTIN, TX (November 8, 2004) – Emerson Process Management and GE Healthcare announced last week a global marketing agreement to provide solutions for protein purification – a critical operation in manufacturing of biotech medicines.

TOPICS:

FDA Issues Warning on Two Sexual Enhancement ‘Dietary Supplements’

November 8, 2004 11:32 am | Product Releases | Comments

WASHINGTON, DC (November 8, 2004) – The Food & Drug Administration last week warned consumers not to purchase or consume Actra-Rx or Yilishen, two products promoted and offered for sale on Web sites as "dietary supplements" for treating erectile dysfunction and enhancing sexual performance for men.

TOPICS:

Terrorism Fears Spur Production of Mobile Command Centers

November 2, 2004 4:17 am | Product Releases | Comments

NEWTON, TX (November 2, 2004) – Mobile Medical & Command CentersInc. has begun marketing specialized mobile command centers for use by municipalities during times of crisis, such as when traditional posts have been compromised or destroyed.

TOPICS:
Advertisement

FDA Reorganization Plan Would Eliminate Split Neuropharm Division

November 2, 2004 4:17 am | Product Releases | Comments

WASHINGTON, DC (November 2, 2004) – The Food & Drug Administration (FDA) is planning to split the

TOPICS:

FDA Names Dr. Edward Otto to Head Cellular, Tissue & Gene...

November 2, 2004 4:17 am | Product Releases | Comments

Washington, DC (November 2, 2004) -- The Food & Drug Administration (FDA) has named Dr. Edward Otto as director of the Office of Cellular, Tissue & Gene Therapies within the agency's Center for Biologic Evaluation & Research (CBER). The appointment is effective November 14. Dr.

TOPICS:

Bristol-Myers Squibb Foundation Targets Hepatitis B in China

November 2, 2004 4:17 am | Product Releases | Comments

BOSTON, MA (November 2, 2004) – The Bristol-Myers Squibb Foundation and the China Foundation for

TOPICS:

DuPont Names de Andrade to Biotechnology Advisory Panel

November 2, 2004 4:17 am | Product Releases | Comments

WILMINGTON, DE (November 2, 2004) – DuPont this week announced the addition of Dr. Marcelo Carvalho de Andrade to its external Biotechnology Advisory Panel. Dr.

TOPICS:

Report: $2.6 trillion in products will incorporate emerging nanotechnology

October 25, 2004 12:53 pm | Product Releases | Comments

NEW YORK, NY (October 25, 2004) – Sales of products incorporating emergingnanotechnology will rise from less than 0.1 percent of global manufacturing outputtoday to 15 percent in 2014, totaling $2.6 trillion, according to a new report fromLux Research entitled “Sizing Nanotechnology's Value Chain.

TOPICS:
Advertisement

Abbott Acquires Spine Next, S.A., a Maker of Non-Fusion Spinal Implant

October 25, 2004 12:53 pm | Product Releases | Comments

ABBOTT PARK, IL (October 25, 2004) – Abbott announced the acquisition of Spine Next, S.A., of

TOPICS:

Sanofi-Aventis Plans $1 Billion Generic Business To Support Managed Care

October 25, 2004 12:53 pm | Product Releases | Comments

WASHINGTON, DC (October 25, 2004) – Sanofi-Aventis plans to build a more than $1 billion generic business to help enhance its ability to contract with managed care, The Pink Sheet newsletter reported this week.

TOPICS:

Study: Eli Lilly Drug To Shift Focus From Pain Control to Disease

October 25, 2004 12:53 pm | Product Releases | Comments

WALTHAM, MA (October 25, 2004) – Decision Resources, Inc., a research and advisory firm focusing

TOPICS:

Nastech and Par Enter into Agreement for Nasal Calcitonin

October 25, 2004 12:53 pm | Product Releases | Comments

BOTHELL, WA (October 25, 2004) – Nastech Pharmaceutical Co. Inc. has entered into an exclusive license and supply agreement with Par Pharmaceutical, Inc. for United States distribution and marketing of Nastech’s calcitonin-salmon nasal spray for the treatment of osteoporosis.

TOPICS:

www.quintiles.com

October 22, 2004 12:37 pm | Product Releases | Comments

Drug Development Services Quintiles Transnational helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries.

www.pa.nilfisk-advance.com

October 22, 2004 12:37 pm | Product Releases | Comments

Industrial-Strength Vacuums Heavy-duty Nilfisk and CFM vacuum cleaners efficiently collect everything from food scraps to pharmaceutical powders to bulk materials.

www.enguardsystems.com

October 22, 2004 12:37 pm | Product Releases | Comments

Barrier/Isolator Systems Provide Total Process Containment Systems are ergonomically integrated barrier isolators that allow maximum interaction with the process.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading